Division of Trauma and Surgical Critical Care, Department of Surgery, Orlando Regional Medical Center, Orlando, Florida; Department of Surgical Education, Orlando Regional Medical Center, Orlando, Florida.
NOVA Southeastern University, Kiran Patel College of Allopathic Medicine, Fort Lauderdale, Florida.
J Surg Res. 2024 Aug;300:165-172. doi: 10.1016/j.jss.2024.04.075. Epub 2024 May 29.
We aim to evaluate the association of early versus late venous thromboembolism (VTE) prophylaxis on in-hospital mortality among patients with severe blunt isolated traumatic brain injuries.
Data from the American College of Surgeons Trauma Quality Program Participant Use File for 2017-2021 were analyzed. The target population included adult trauma patients with severe isolated traumatic brain injury (TBI). VTE prophylaxis types (low molecular weight heparin and unfractionated heparin) and their administration timing were analyzed in relation to in-hospital complications and mortality.
The study comprised 3609 patients, predominantly Caucasian males, with an average age of 48.5 y. Early VTE prophylaxis recipients were younger (P < 0.01) and more likely to receive unfractionated heparin (P < 0.01). VTE prophylaxis later than 24 h was associated with a higher average injury severity score and longer intensive care unit stays (P < 0.01). Logistic regression revealed that VTE prophylaxis later than 24 h was associated with significant reduction of in-hospital mortality by 38% (odds ratio 0.62, 95% confidence interval 0.40-0.94, P = 0.02). Additionally, low molecular weight heparin use was associated with decreased mortality odds by 30% (odds ratio 0.70, 95% confidence interval 0.55-0.89, P < 0.01).
VTE prophylaxis later than 24 h is associated with a reduced risk of in-hospital mortality in patients with severe isolated blunt TBI, as opposed to VTE prophylaxis within 24 h. These findings suggest the need for timely and appropriate VTE prophylaxis in TBI care, highlighting the critical need for a comprehensive assessment and further research concerning the safety and effectiveness of VTE prophylaxis in these patient populations.
我们旨在评估严重钝性孤立性创伤性脑损伤患者中早期与晚期静脉血栓栓塞(VTE)预防对住院死亡率的影响。
分析了 2017 年至 2021 年美国外科医师学院创伤质量计划参与者使用文件的数据。目标人群包括患有严重孤立性创伤性脑损伤(TBI)的成年创伤患者。分析了 VTE 预防类型(低分子肝素和未分级肝素)及其给药时间与住院并发症和死亡率的关系。
该研究包括 3609 例患者,主要为白种男性,平均年龄为 48.5 岁。早期 VTE 预防组患者年龄较小(P<0.01),更有可能接受未分级肝素(P<0.01)。VTE 预防时间晚于 24 小时与较高的平均损伤严重程度评分和较长的重症监护病房住院时间相关(P<0.01)。Logistic 回归显示,VTE 预防时间晚于 24 小时与住院死亡率显著降低 38%相关(比值比 0.62,95%置信区间 0.40-0.94,P=0.02)。此外,低分子肝素的使用与降低 30%的死亡率相关(比值比 0.70,95%置信区间 0.55-0.89,P<0.01)。
与 24 小时内的 VTE 预防相比,严重孤立性钝性 TBI 患者中 VTE 预防时间晚于 24 小时与住院死亡率降低相关。这些发现表明,TBI 护理中需要及时和适当的 VTE 预防,强调了对这些患者群体中 VTE 预防的安全性和有效性进行全面评估和进一步研究的迫切需要。